Inactive Instrument

Generex Biotechnology Corporation Stock Other OTC

Equities

GNBT

US3714853013

Biotechnology & Medical Research

Dynamic Chart
Motion for Asset Sale Approved for Generex Biotechnology Corporation CI
Motion for Asset Sale Filed by Generex Biotechnology Corporation CI
Motion for Asset Sale Approved for Generex Biotechnology Corporation CI
Amended Bidding Procedure Approved for Generex Biotechnology Corporation CI
Involuntary Petition Approved for Generex Biotechnology Corporation CI
Involuntary Petition Filed Against Generex Biotechnology Corporation CI
Generex Biotechnology Corporation Enters into Quality Agreement with PPD Development, L.P CI
Generex Biotechnology Corporation announced that it has received $1 million in funding CI
Generex Biotechnology Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021 CI
Generex Biotechnology Corporation Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring Services CI
Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement CI
Generex Provides Update on Its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development CI
Generex Biotechnology Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021 CI
Generex Biotechnology Corporation Completes Mouse Immunogenicity Study CI
Generex Biotechnology Corporation announced that it has received $1.425 million in funding CI
More news
Managers TitleAgeSince
Chief Executive Officer 61 17-11-20
Director of Finance/CFO - 16-12-31
Chief Operating Officer 65 18-06-24
Members of the board TitleAgeSince
Director/Board Member 63 04-02-29
Corporate Officer/Principal 66 04-12-31
Director/Board Member 57 17-11-20
More insiders
Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities. It is focused on building an organizational platform for the financing, development, commercialization and distribution of promising devices, biologics, therapeutic and diagnostic products to improve human health. The Company's subsidiary includes NuGenerex family of companies: NuGenerex Immuno-Oncology, Inc., NuGenerex Diagnostics, NuGenerex Health, LLC, NuGenerex Regenerative Medicine (NRM), NuGenerex Diagnostics (NGD), and NuGenerex Therapeutics. NuGenerex Immuno-Oncology, Inc. is a platform biotechnology company focused on improving the innate immune system to treat and prevent cancer and infectious disease with a pipeline of immunotherapy indications based on its patented platform technology.
More about the company